Cargando…
Neuroprotective effects of VCP modulators in mouse models of glaucoma
Glaucoma is a major cause of adult blindness due to gradual death of retinal ganglion cells. Currently, no therapeutics are available for the protection of these cells from the cell death. We have recently succeeded in synthesizing novel compounds, KUSs (Kyoto University Substances), which can reduc...
Autores principales: | Nakano, Noriko, Ikeda, Hanako Ohashi, Hasegawa, Tomoko, Muraoka, Yuki, Iwai, Sachiko, Tsuruyama, Tatsuaki, Nakano, Masaki, Fuchigami, Tomohiro, Shudo, Toshiyuki, Kakizuka, Akira, Yoshimura, Nagahisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946081/ https://www.ncbi.nlm.nih.gov/pubmed/27441270 http://dx.doi.org/10.1016/j.heliyon.2016.e00096 |
Ejemplares similares
-
Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration
por: Hasegawa, Tomoko, et al.
Publicado: (2016) -
Novel VCP modulators mitigate major pathologies of rd10, a mouse model of retinitis pigmentosa
por: Ikeda, Hanako Ohashi, et al.
Publicado: (2014) -
Branched chain amino acids attenuate major pathologies in mouse models of retinal degeneration and glaucoma
por: Hasegawa, Tomoko, et al.
Publicado: (2018) -
KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
por: Hata, Masayuki, et al.
Publicado: (2017) -
Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
por: Hasegawa, Tomoko, et al.
Publicado: (2020)